TELO
Telomir Pharmaceuticals, Inc.
0.5950
+0.02 (+2.73%)
52w low 0.5450
1.58 high
4.8% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 1.42K | 1.23K | 1.27M | 7.29M | |
| Receivables | -- | 0.00 | 130.00K | 0.00 | -- | |
| Current Assets | -- | 48.73K | 435.23K | 1.32M | 7.34M | |
| Total Assets | -- | 48.73K | 4.77M | 1.32M | 7.34M | |
| Current Liabilities | -- | 986.01K | 1.34M | 680.97K | 1.43M | |
| Total Debt | -- | -- | 101.00K | -- | -- | |
| Total Liabilities | -- | 986.01K | 1.34M | 680.97K | 1.43M | |
| Retained Earnings | -- | -992.28K | -14.06M | -30.60M | -41.01M | |
| Shareholders Equity | -- | -937.28K | 3.44M | 643.04K | 5.91M | |
| Working Capital | -- | -937.28K | -900.34K | 643.04K | 5.91M | |
| Shares Outstanding | -- | 29.61M | 29.61M | 29.76M | 34.38M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--